ZIOP
Price:
$0.8657
Market Cap:
$208.12M
ZIOPHARM Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing a portfolio of immuno-oncology therapies to treat patients with cancer. The company develops Sleeping Beauty platform, which is based on the non-viral genetic engineering of immune cells using a transposon/transposase system to engineer T-cells outside of the body for infusion; and Controlled IL-12 to stimulate expression of interleukin 12 or IL-12, a master regular of the immune system, in a controlled manner to focus the patient's immune system to attack cancer cells. Its product candidates include T cell receptor + T therapies to target solid tumors; chim...[Read more]
Industry
Biotechnology
IPO Date
2004-08-20
Stock Exchange
NASDAQ
Ticker
ZIOP
According to ZIOPHARM Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 97.87M. This represents a change of -79.66% compared to the average of 481.19M of the last 4 quarters.
The mean historical Enterprise Value of ZIOPHARM Oncology, Inc. over the last ten years is 456.89M. The current 97.87M Enterprise Value has changed 2.04% with respect to the historical average. Over the past ten years (40 quarters), ZIOP's Enterprise Value was at its highest in in the June 2015 quarter at 1.42B. The Enterprise Value was at its lowest in in the March 2013 quarter at 90.26M.
Average
456.89M
Median
443.98M
Minimum
186.36M
Maximum
901.49M
Discovering the peaks and valleys of ZIOPHARM Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 245.56%
Maximum Annual Enterprise Value = 901.49M
Minimum Annual Increase = -58.26%
Minimum Annual Enterprise Value = 186.36M
Year | Enterprise Value | Change |
---|---|---|
2020 | 418.03M | -41.56% |
2019 | 715.34M | 245.56% |
2018 | 207.01M | -58.26% |
2017 | 495.98M | -19.55% |
2016 | 616.54M | -31.61% |
2015 | 901.49M | 91.84% |
2014 | 469.93M | 54.18% |
2013 | 304.79M | 20.26% |
2012 | 253.45M | 36.00% |
2011 | 186.36M | 21.03% |
The current Enterprise Value of ZIOPHARM Oncology, Inc. (ZIOP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
446.79M
5-year avg
490.58M
10-year avg
456.89M
ZIOPHARM Oncology, Inc.’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ZIOPHARM Oncology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ZIOPHARM Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ZIOPHARM Oncology, Inc.'s Enterprise Value?
What is the highest Enterprise Value for ZIOPHARM Oncology, Inc. (ZIOP)?
What is the 3-year average Enterprise Value for ZIOPHARM Oncology, Inc. (ZIOP)?
What is the 5-year average Enterprise Value for ZIOPHARM Oncology, Inc. (ZIOP)?
How does the current Enterprise Value for ZIOPHARM Oncology, Inc. (ZIOP) compare to its historical average?